BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 28399565)

  • 1. Conducting Privacy-Preserving Multivariable Propensity Score Analysis When Patient Covariate Information Is Stored in Separate Locations.
    Bohn J; Eddings W; Schneeweiss S
    Am J Epidemiol; 2017 Mar; 185(6):501-510. PubMed ID: 28399565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivariate-adjusted pharmacoepidemiologic analyses of confidential information pooled from multiple health care utilization databases.
    Rassen JA; Avorn J; Schneeweiss S
    Pharmacoepidemiol Drug Saf; 2010 Aug; 19(8):848-57. PubMed ID: 20162632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multivariable confounding adjustment in distributed data networks without sharing of patient-level data.
    Toh S; Reichman ME; Houstoun M; Ding X; Fireman BH; Gravel E; Levenson M; Li L; Moyneur E; Shoaibi A; Zornberg G; Hennessy S
    Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1171-7. PubMed ID: 23878013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bias in pharmacoepidemiologic studies using secondary health care databases: a scoping review.
    Prada-Ramallal G; Takkouche B; Figueiras A
    BMC Med Res Methodol; 2019 Mar; 19(1):53. PubMed ID: 30871502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Privacy-preserving Statistical Query and Processing on Distributed OpenEHR Data.
    Hailemichael MA; Marco-Ruiz L; Bellika JG
    Stud Health Technol Inform; 2015; 210():766-70. PubMed ID: 25991257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of disease risk scores in pharmacoepidemiologic studies.
    Arbogast PG; Ray WA
    Stat Methods Med Res; 2009 Feb; 18(1):67-80. PubMed ID: 18562398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Privacy preserving probabilistic record linkage (P3RL): a novel method for linking existing health-related data and maintaining participant confidentiality.
    Schmidlin K; Clough-Gorr KM; Spoerri A;
    BMC Med Res Methodol; 2015 May; 15():46. PubMed ID: 26024886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity of Privacy-Protecting Analytical Methods That Use Only Aggregate-Level Information to Conduct Multivariable-Adjusted Analysis in Distributed Data Networks.
    Li X; Fireman BH; Curtis JR; Arterburn DE; Fisher DP; Moyneur É; Gallagher M; Raebel MA; Nowell WB; Lagreid L; Toh S
    Am J Epidemiol; 2019 Apr; 188(4):709-723. PubMed ID: 30535131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Data safety and drug safety in Germany: a closing gap?
    Rathmann W
    Pharmacoepidemiol Drug Saf; 2001 Dec; 10(7):625-30. PubMed ID: 11980251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating privacy-preserving record linkage using cryptographic long-term keys and multibit trees on large medical datasets.
    Brown AP; Borgs C; Randall SM; Schnell R
    BMC Med Inform Decis Mak; 2017 Jun; 17(1):83. PubMed ID: 28595638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secure and scalable deduplication of horizontally partitioned health data for privacy-preserving distributed statistical computation.
    Yigzaw KY; Michalas A; Bellika JG
    BMC Med Inform Decis Mak; 2017 Jan; 17(1):1. PubMed ID: 28049465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addressing data privacy in matched studies via virtual pooling.
    Saha-Chaudhuri P; Weinberg CR
    BMC Med Res Methodol; 2017 Sep; 17(1):136. PubMed ID: 28882105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Privacy considerations in the context of an Australian observational database.
    Duszynski KM; Beilby JJ; Marley JE; Walker DC; Pratt NL
    Pharmacoepidemiol Drug Saf; 2001 Dec; 10(7):587-94. PubMed ID: 11980245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited privacy protection and poor sensitivity: Is it time to move on from the statistical linkage key-581?
    Randall SM; Ferrante AM; Boyd JH; Brown AP; Semmens JB
    Health Inf Manag; 2016 Aug; 45(2):71-9. PubMed ID: 27178751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An 'Honest Broker' mechanism to maintain privacy for patient care and academic medical research.
    Boyd AD; Hosner C; Hunscher DA; Athey BD; Clauw DJ; Green LA
    Int J Med Inform; 2007; 76(5-6):407-11. PubMed ID: 17081800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of privacy-protecting analytic and data-sharing methods: A simulation study.
    Yoshida K; Gruber S; Fireman BH; Toh S
    Pharmacoepidemiol Drug Saf; 2018 Sep; 27(9):1034-1041. PubMed ID: 30022561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concept for linking de-identified biomedical research data using a study participant management system.
    Stahmann A; Bauer CR; Schwanke J
    Stud Health Technol Inform; 2014; 205():848-52. PubMed ID: 25160307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Devil's in the details: Reports on reproducibility in pharmacoepidemiologic studies.
    Petrone AB; DuCott A; Gagne JJ; Toh S; Maro JC
    Pharmacoepidemiol Drug Saf; 2019 May; 28(5):671-679. PubMed ID: 30843303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient records: case studies. Return to the source. How health researchers are already using pseudonymisation of data at source.
    Health Serv J; 2014 May; 124(6400):suppl 4-5. PubMed ID: 25137757
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparing the performance of propensity score methods in healthcare database studies with rare outcomes.
    Franklin JM; Eddings W; Austin PC; Stuart EA; Schneeweiss S
    Stat Med; 2017 May; 36(12):1946-1963. PubMed ID: 28208229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.